Cargando…

Role of Dapagliflozin and Liraglutide on Diabetes-Induced Cardiomyopathy in Rats: Implication of Oxidative Stress, Inflammation, and Apoptosis

The current study aims to assess the protective effects of dapagliflozin (Dapa; a sodium-glucose cotransporter-2 inhibitor) and/or liraglutide (Lira; a glucagon-like peptide 1 agonist) in an experimental model of diabetic cardiomyopathy (DCM). A single dose of streptozotocin (STZ) was administrated...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Shafey, Mohamed, El-Agawy, Mosaab Salah El-din, Eldosoky, Mohamed, Ebrahim, Hasnaa Ali, Elsherbini, Dalia Mahmoud Abdelmonem, El-Sherbiny, Mohamed, Asseri, Saad Mohamed, Elsherbiny, Nehal M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972060/
https://www.ncbi.nlm.nih.gov/pubmed/35370937
http://dx.doi.org/10.3389/fendo.2022.862394
_version_ 1784679768016289792
author El-Shafey, Mohamed
El-Agawy, Mosaab Salah El-din
Eldosoky, Mohamed
Ebrahim, Hasnaa Ali
Elsherbini, Dalia Mahmoud Abdelmonem
El-Sherbiny, Mohamed
Asseri, Saad Mohamed
Elsherbiny, Nehal M.
author_facet El-Shafey, Mohamed
El-Agawy, Mosaab Salah El-din
Eldosoky, Mohamed
Ebrahim, Hasnaa Ali
Elsherbini, Dalia Mahmoud Abdelmonem
El-Sherbiny, Mohamed
Asseri, Saad Mohamed
Elsherbiny, Nehal M.
author_sort El-Shafey, Mohamed
collection PubMed
description The current study aims to assess the protective effects of dapagliflozin (Dapa; a sodium-glucose cotransporter-2 inhibitor) and/or liraglutide (Lira; a glucagon-like peptide 1 agonist) in an experimental model of diabetic cardiomyopathy (DCM). A single dose of streptozotocin (STZ) was administrated to male Sprague–Dawley rats by intraperitoneal injection at a dose of 50 mg/kg to induce diabetes mellitus (DM). Dapa (1 mg/kg, orally), Lira (0.4 mg/kg, s.c.), and Dapa–Lira combination were administrated for 8 weeks once-daily. Blood samples were evaluated for glucose level and biochemical markers of cardiac functions. Cardiac tissue was dissected and assessed for redox homeostasis (malondialdehyde (MDA), glutathione (GSH), and catalase (CAT)), pro-inflammatory mediators (NF-κB and tumor necrosis factor-α (TNF-α)), and apoptotic effectors (caspase-3). Moreover, the effect of treatments on the cardiac cellular structure was studied. Dapa and/or Lira administration resulted in significant improvement of biochemical indices of cardiac function. Additionally, all treatment groups demonstrated restoration of oxidant/antioxidant balance. Moreover, inflammation and apoptosis key elements were markedly downregulated in cardiac tissue. Also, histological studies demonstrated attenuation of diabetes-induced cardiac tissue injury. Interestingly, Dapa–Lira combination treatment produced a more favorable protective effect as compared to a single treatment. These data demonstrated that Dapa, Lira, and their combination therapy could be useful in protection against DM-accompanied cardiac tissue injury, shedding the light on their possible utilization as adjuvant therapy for the management of DM patients.
format Online
Article
Text
id pubmed-8972060
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89720602022-04-02 Role of Dapagliflozin and Liraglutide on Diabetes-Induced Cardiomyopathy in Rats: Implication of Oxidative Stress, Inflammation, and Apoptosis El-Shafey, Mohamed El-Agawy, Mosaab Salah El-din Eldosoky, Mohamed Ebrahim, Hasnaa Ali Elsherbini, Dalia Mahmoud Abdelmonem El-Sherbiny, Mohamed Asseri, Saad Mohamed Elsherbiny, Nehal M. Front Endocrinol (Lausanne) Endocrinology The current study aims to assess the protective effects of dapagliflozin (Dapa; a sodium-glucose cotransporter-2 inhibitor) and/or liraglutide (Lira; a glucagon-like peptide 1 agonist) in an experimental model of diabetic cardiomyopathy (DCM). A single dose of streptozotocin (STZ) was administrated to male Sprague–Dawley rats by intraperitoneal injection at a dose of 50 mg/kg to induce diabetes mellitus (DM). Dapa (1 mg/kg, orally), Lira (0.4 mg/kg, s.c.), and Dapa–Lira combination were administrated for 8 weeks once-daily. Blood samples were evaluated for glucose level and biochemical markers of cardiac functions. Cardiac tissue was dissected and assessed for redox homeostasis (malondialdehyde (MDA), glutathione (GSH), and catalase (CAT)), pro-inflammatory mediators (NF-κB and tumor necrosis factor-α (TNF-α)), and apoptotic effectors (caspase-3). Moreover, the effect of treatments on the cardiac cellular structure was studied. Dapa and/or Lira administration resulted in significant improvement of biochemical indices of cardiac function. Additionally, all treatment groups demonstrated restoration of oxidant/antioxidant balance. Moreover, inflammation and apoptosis key elements were markedly downregulated in cardiac tissue. Also, histological studies demonstrated attenuation of diabetes-induced cardiac tissue injury. Interestingly, Dapa–Lira combination treatment produced a more favorable protective effect as compared to a single treatment. These data demonstrated that Dapa, Lira, and their combination therapy could be useful in protection against DM-accompanied cardiac tissue injury, shedding the light on their possible utilization as adjuvant therapy for the management of DM patients. Frontiers Media S.A. 2022-03-18 /pmc/articles/PMC8972060/ /pubmed/35370937 http://dx.doi.org/10.3389/fendo.2022.862394 Text en Copyright © 2022 El-Shafey, El-Agawy, Eldosoky, Ebrahim, Elsherbini, El-Sherbiny, Asseri and Elsherbiny https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
El-Shafey, Mohamed
El-Agawy, Mosaab Salah El-din
Eldosoky, Mohamed
Ebrahim, Hasnaa Ali
Elsherbini, Dalia Mahmoud Abdelmonem
El-Sherbiny, Mohamed
Asseri, Saad Mohamed
Elsherbiny, Nehal M.
Role of Dapagliflozin and Liraglutide on Diabetes-Induced Cardiomyopathy in Rats: Implication of Oxidative Stress, Inflammation, and Apoptosis
title Role of Dapagliflozin and Liraglutide on Diabetes-Induced Cardiomyopathy in Rats: Implication of Oxidative Stress, Inflammation, and Apoptosis
title_full Role of Dapagliflozin and Liraglutide on Diabetes-Induced Cardiomyopathy in Rats: Implication of Oxidative Stress, Inflammation, and Apoptosis
title_fullStr Role of Dapagliflozin and Liraglutide on Diabetes-Induced Cardiomyopathy in Rats: Implication of Oxidative Stress, Inflammation, and Apoptosis
title_full_unstemmed Role of Dapagliflozin and Liraglutide on Diabetes-Induced Cardiomyopathy in Rats: Implication of Oxidative Stress, Inflammation, and Apoptosis
title_short Role of Dapagliflozin and Liraglutide on Diabetes-Induced Cardiomyopathy in Rats: Implication of Oxidative Stress, Inflammation, and Apoptosis
title_sort role of dapagliflozin and liraglutide on diabetes-induced cardiomyopathy in rats: implication of oxidative stress, inflammation, and apoptosis
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972060/
https://www.ncbi.nlm.nih.gov/pubmed/35370937
http://dx.doi.org/10.3389/fendo.2022.862394
work_keys_str_mv AT elshafeymohamed roleofdapagliflozinandliraglutideondiabetesinducedcardiomyopathyinratsimplicationofoxidativestressinflammationandapoptosis
AT elagawymosaabsalaheldin roleofdapagliflozinandliraglutideondiabetesinducedcardiomyopathyinratsimplicationofoxidativestressinflammationandapoptosis
AT eldosokymohamed roleofdapagliflozinandliraglutideondiabetesinducedcardiomyopathyinratsimplicationofoxidativestressinflammationandapoptosis
AT ebrahimhasnaaali roleofdapagliflozinandliraglutideondiabetesinducedcardiomyopathyinratsimplicationofoxidativestressinflammationandapoptosis
AT elsherbinidaliamahmoudabdelmonem roleofdapagliflozinandliraglutideondiabetesinducedcardiomyopathyinratsimplicationofoxidativestressinflammationandapoptosis
AT elsherbinymohamed roleofdapagliflozinandliraglutideondiabetesinducedcardiomyopathyinratsimplicationofoxidativestressinflammationandapoptosis
AT asserisaadmohamed roleofdapagliflozinandliraglutideondiabetesinducedcardiomyopathyinratsimplicationofoxidativestressinflammationandapoptosis
AT elsherbinynehalm roleofdapagliflozinandliraglutideondiabetesinducedcardiomyopathyinratsimplicationofoxidativestressinflammationandapoptosis